报告题目：Pharmaceutical sciences and clinical pharmacy Education in the United States -- the University at Buffalo as an example
（美国药学和临床药学教育现状与发展
--纽约州立大学布法罗分校药学院解析）
报告人：James M O’Donnell, PhD
Dean and Professor
School of Pharmacy & Pharmaceutical Sciences, University at Buffalo
The State University of New York
报告时间：2017年6月8日 16：00
报告地点：图书馆学术报告厅
欢迎广大师生踊跃参加！
科研处 药学院
2017年6月6日
报告人简介：Dr. O'Donnell is dean of the School of Pharmacy and Pharmaceutical Sciences at the State University of New York at Buffalo. He is also professor of Department of Pharmaceutical Sciences and Department of Pharmacology and Toxicology at SUNY Buffalo. Dr. O'Donnell has long-standing interest and expertise in neuropsychopharmacology. His research over the last 30 years has focused on elucidating the molecular mechanisms of action of CNS drugs and identifying novel molecular targets mediating antidepressant, anxiolytic, and memory-enhancing effects on behavior. Recently, his research team is interested in exploring roles of phosphodiesterase (PDE)-mediated cAMP/cGMP signaling in neuropsychiatric and neurodegenerative diseases and developing novel drugs for treatment of these disorders. He has published more than 100 peer-reviewed papers in high impact journals. He is honored as AAAS fellow since 2016, in recognition of his contributions to innovation and scientific leadership. Dr. O’Donnell’s research achievement is well-documented in his grant applications from NIH. In addition to research and research administration, Dr. O'Donnell is also highly active in other academic activities. He is the chair of the Pathophysiological Basis of Mental Disorders and Addiction study section for NIH and the chair for the 2010 Gordon Research Conference on Cyclic Nucleotide Phosphodiesterases. He also serves as associate editor for the Journal of Pharmacology and Experimental Therapeutics and editorial board member of 26 peer-reviewed journals.
